Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3158625rdf:typepubmed:Citationlld:pubmed
pubmed-article:3158625lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3158625lifeskim:mentionsumls-concept:C0221002lld:lifeskim
pubmed-article:3158625lifeskim:mentionsumls-concept:C1268930lld:lifeskim
pubmed-article:3158625lifeskim:mentionsumls-concept:C0008783lld:lifeskim
pubmed-article:3158625lifeskim:mentionsumls-concept:C0019588lld:lifeskim
pubmed-article:3158625lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3158625pubmed:issue2lld:pubmed
pubmed-article:3158625pubmed:dateCreated1985-7-17lld:pubmed
pubmed-article:3158625pubmed:abstractTextThe possibility of a link between parathyroid hyperfunction and cellular immune functions was studied in primary hyperparathyroid (1 degree HP) patients. The effect of cimetidine on lymphocyte functions in 1 degree HP patients and control subjects was also investigated. Histamine-induced suppressor activity of lymphocytes from 1 degree HP patients was significantly greater than that of controls. Cimetidine addition to both normal and 1 degree HP lymphocyte cultures abolished histamine-induced suppression. In vivo administration of cimetidine, while ineffective towards normal lymphocytes, depressed phytohemagglutinin stimulation of 1 degree HP lymphocytes, indicating possible immunological damage caused by this drug, which is frequently used in the treatment of patients with 1 degree HP.lld:pubmed
pubmed-article:3158625pubmed:languageenglld:pubmed
pubmed-article:3158625pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158625pubmed:citationSubsetIMlld:pubmed
pubmed-article:3158625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3158625pubmed:statusMEDLINElld:pubmed
pubmed-article:3158625pubmed:monthAprlld:pubmed
pubmed-article:3158625pubmed:issn0162-3109lld:pubmed
pubmed-article:3158625pubmed:authorpubmed-author:LahatNNlld:pubmed
pubmed-article:3158625pubmed:authorpubmed-author:OKUKKlld:pubmed
pubmed-article:3158625pubmed:authorpubmed-author:KraiemZZlld:pubmed
pubmed-article:3158625pubmed:authorpubmed-author:GlaserBBlld:pubmed
pubmed-article:3158625pubmed:authorpubmed-author:SheinfeldMMlld:pubmed
pubmed-article:3158625pubmed:authorpubmed-author:RotemMMlld:pubmed
pubmed-article:3158625pubmed:issnTypePrintlld:pubmed
pubmed-article:3158625pubmed:volume9lld:pubmed
pubmed-article:3158625pubmed:ownerNLMlld:pubmed
pubmed-article:3158625pubmed:authorsCompleteYlld:pubmed
pubmed-article:3158625pubmed:pagination81-6lld:pubmed
pubmed-article:3158625pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3158625pubmed:meshHeadingpubmed-meshheading:3158625-...lld:pubmed
pubmed-article:3158625pubmed:meshHeadingpubmed-meshheading:3158625-...lld:pubmed
pubmed-article:3158625pubmed:meshHeadingpubmed-meshheading:3158625-...lld:pubmed
pubmed-article:3158625pubmed:meshHeadingpubmed-meshheading:3158625-...lld:pubmed
pubmed-article:3158625pubmed:meshHeadingpubmed-meshheading:3158625-...lld:pubmed
pubmed-article:3158625pubmed:meshHeadingpubmed-meshheading:3158625-...lld:pubmed
pubmed-article:3158625pubmed:meshHeadingpubmed-meshheading:3158625-...lld:pubmed
pubmed-article:3158625pubmed:meshHeadingpubmed-meshheading:3158625-...lld:pubmed
pubmed-article:3158625pubmed:meshHeadingpubmed-meshheading:3158625-...lld:pubmed
pubmed-article:3158625pubmed:year1985lld:pubmed
pubmed-article:3158625pubmed:articleTitleCellular immune functions in patients with primary hyperparathyroidism: effects of histamine and cimetidine.lld:pubmed
pubmed-article:3158625pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3158625pubmed:publicationTypeIn Vitrolld:pubmed